Rachel Curtis Gravesen
Director/Board Member chez CESSATECH A/S
Profil
Rachel Curtis Gravesen is currently a Director at Cessatech A since 2022.
Prior to this, she worked as a Communications Manager at Novo Nordisk A.
From 2011 to 2019, she served as Senior VP-Investor Relations & Communications at Genmab A.
She also worked as Vice President-Investor Relations at Pharmaceutical Development Center.
Ms. Gravesen is a graduate of St. John's College, Cambridge and City University London.
Postes actifs de Rachel Curtis Gravesen
Sociétés | Poste | Début |
---|---|---|
CESSATECH A/S | Director/Board Member | 17/03/2022 |
Anciens postes connus de Rachel Curtis Gravesen
Sociétés | Poste | Fin |
---|---|---|
GENMAB A/S | Investor Relations Contact | 11/03/2019 |
NOVO NORDISK A/S | Public Communications Contact | - |
Pharmaceutical Development Center
Pharmaceutical Development Center Miscellaneous Commercial ServicesCommercial Services Part of AAIPharma, Inc., Pharmaceutical Development Center researches and develops pharmaceutical products. The private company is based in Charlotte, NC. Pharmaceutical Development Center was acquired by AAIPharma, Inc. on July 31, 2001. | Public Communications Contact | - |
Formation de Rachel Curtis Gravesen
St. John's College, Cambridge | Graduate Degree |
City University London | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
NOVO NORDISK A/S | Health Technology |
GENMAB A/S | Health Technology |
CESSATECH A/S | Health Technology |
Entreprise privées | 1 |
---|---|
Pharmaceutical Development Center
Pharmaceutical Development Center Miscellaneous Commercial ServicesCommercial Services Part of AAIPharma, Inc., Pharmaceutical Development Center researches and develops pharmaceutical products. The private company is based in Charlotte, NC. Pharmaceutical Development Center was acquired by AAIPharma, Inc. on July 31, 2001. | Commercial Services |